NCT05890144 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Allan, B
& Smylie, J. First Peoples, second class treatment: The role of racism in the health and well-being of Indigenous peoples in Canada. Toronto, ON: The Wellesley Institute. 2015
Brian Sinclair Working Group
Out of Sight. 2017. Accessed from: http://ignoredtodeathmanitoba.ca/index.php/2017/09/15/out-of-sight-interim-report-of-the-sinclair-working-group/
Devine PG, Forscher PS, Austin AJ, Cox WT
Long-term reduction in implicit race bias: A prejudice habit-breaking intervention. J Exp Soc Psychol. 2012 Nov;48(6):1267-1278. doi: 10.1016/j.jesp.2012.06.003.
Morrison MA, Morrison TG, Harriman RL, Jewell LM
Old-fashioned and modern prejudice towards Aboriginals in Canada. In book: The Psychology of Modern Prejudice, (Ed): Morrison Melanie A., Morrison Todd G., Nova Science Publishers., Inc. 2015 pp.277-305.
Truth and Reconciliation Canada
Honouring the truth, reconciling for the future: summary of the final report of the Truth and reconciliation Commission of Canada. Winnipeg: Truth and Reconciliation Commission of Canada. 2015

Reconciling Relationships - An RCT Examining Relational and Clinical Decision-Making Impacts of Intensive, Brief and Control Indigenous Cultural Safety Training Interventions for Health Care Providers

Details for clinical trial NCT05890144

Clinical trial NCT05890144 - References